EDGAR Filing Documents for 0001354488-13-000988

Form 8-K - Current report:

SEC Accession No. 0001354488-13-000988

Filing Date

2013-03-05

Accepted

2013-03-05 15:01:44

Documents

Period of Report

2013-02-27

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	tbuff_8k.htm	8-K	30942
2	SECURITIES PURCHASE AGREEMENT	tbuff_ex101.htm	EX-10.1	277227
3	REGISTRATION RIGHTS AGREEMENT	tbuff_ex102.htm	EX-10.2	172843
4	SERIES A/B WARRANT	tbuff_ex103.htm	EX-10.3	116120
5	PRESS RELEASE	tbuff_ex991.htm	EX-99.1	3768
6		tbuff_ex991001.jpg	GRAPHIC	433557
7		tbuff_ex991002.jpg	GRAPHIC	454975
8		tbuff_ex991003.jpg	GRAPHIC	354357
	Complete submission text file	0001354488-13-000988.txt		2315035

Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8

Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540

Tribute Pharmaceuticals Canada Inc. (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31198 | Film No.: 13665323
SIC: 2834 Pharmaceutical Preparations